- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.07. | IceCure Medical receives non-compliance notice for continued listing from Nasdaq | 1 | Seeking Alpha | ||
| 16.07. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.07. | IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint | 1 | Zacks | ||
| 09.07. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.07. | IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod | 1 | Zacks | ||
| 01.07. | FDA clears IceCure Medical's next-gen single-probe cryoablation system | 1 | MassDevice | ||
| 01.07. | IceCure Medical Says FDA Clears Next-Gen XSense Cryoablation System With CryoProbes | - | RTTNews | ||
| 01.07. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 01.07. | IceCure Medical: U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense Cryoablation System with CryoProbes | 54 | PR Newswire | CAESAREA, Israel, July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that... ► Artikel lesen | |
| 04.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | IceCure Medical: FDA to Convene Advisory Panel for Review of IceCure's De Novo Marketing Clearance Request for ProSense, Decision Expected Early 2025; Aligns with Commercial Readiness Plan | 54 | PR Newswire | Demonstrates public health importance of assessing ProSense®'s potential to offer optimal treatment that benefits women with early-stage breast cancer
Patients, patient advocacy groups, doctors, and... ► Artikel lesen | |
| 28.05. | IceCure Medical GAAP EPS of -$0.08 in-line, revenue of $0.74M misses by $0.14M | 1 | Seeking Alpha | ||
| 28.05. | IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024 | 265 | PR Newswire | 30% sales growth reflects continued adoption of ProSense® in the U.S. and other global markets
Major milestones achieved: - Completion of landmark ICE3 trial for breast cancer - Positive final ICE3... ► Artikel lesen | |
| 21.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 18.04. | IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA | 1 | Zacks | ||
| 17.04. | BTTR, ICCM and SXTC among pre-market losers | 3 | Seeking Alpha | ||
| 15.04. | IceCure submits final breast cancer cryoablation data to FDA | 1 | MassDevice | ||
| 15.04. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.04. | IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer | 100 | PR Newswire | Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fine wins Scientific Impact Award as voted by breast surgeons
President-Elect of... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -2,56 % bei einem Aktienkurs von 0,760 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.
